Preview

Tumors of female reproductive system

Advanced search

R1 resection margin after organ-sparing/oncoplastic surgeries for breast cancer

https://doi.org/10.17650/1994-4098-2021-17-1-12-19

Abstract

The recurrence rate after organ-sparing surgeries for breast cancer depends on the resection margins: R1 status is associated with a higher risk of recurrence than R0.
We analyzed a group of breast cancer patients with an R1 resection margin who underwent organ-sparing/oncoplastic surgeries. The R1 resection margin was detected in 62 out of 1279 patients who had organ-sparing/oncoplastic surgeries (4.9 % ± 0.6 %). In the group with invasive cancer and R1 resection margin, 80 % of patients were diagnosed with lobular carcinoma, whereas 14.8 % of patients had invasive cancer with no specific signs.
We divided the group of repeated surgeries according to their histological structure at the resection margin: 28 patients were found to have carcinoma in situ, while 13 patients had invasive cancer.
Among patients with carcinoma in situ, the resection margin after repeated surgery had no signs of malignancy in 14 women (50 %), while 10 (35.7 %) and 4 (14.3 %) women were diagnosed with carcinoma in situ and invasive cancer, respectively.
In case of invasive cancer, 4 patients (30.8 %) had no signs of malignancy in their resection margins, while 1 (7.7 %) and 8 (61.5 %) patients were found to have carcinoma in situ and invasive cancer, respectively
Follow-up of patients with an R1 resection margin after repeated surgery or radiotherapy revealed no cases of local recurrence between 3 and 65 months.

About the Authors

E.  A.  Rasskazova
P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia
Russian Federation

Elena Aleksandrovna Rasskazova  

3 2 nd Botkinskiy Proezd, Moscow 125284



A.  D.  Zikiryakhodzhaev
P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia; Institute of Medicine, Peoples’ Friendship University of Russia
Russian Federation

3 2 nd Botkinskiy Proezd, Moscow 125284

Build. 2, 8 Trubetskaya St., Moscow 119991

8 Miklukho-Maklaya St., Moscow 117198



N.  N.  Volchenko
P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia
Russian Federation

3 2 nd Botkinskiy Proezd, Moscow 125284



Sh.  G.  Khakimova
P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia
Russian Federation

3 2 nd Botkinskiy Proezd, Moscow 125284



References

1. Пожарийский К.М., Куйдабергенова А.Г., Савелов Н.А. и др. Клинические рекомендации Российского общества онкомаммологов по патологоанатомиическому исследованию рака молочной железы. Доступно по: http://www.breastcancersociety.ru/rek/view/29. [Pozhariyskiy K.M., Kuydabergenova A.G., Savelov N.A. et al. Clinical guideline on pathological examination of breast cancer by the Russian Association of Oncological Mammology. Available at: http://www.breastcancersociety.ru/rek/view/29. (In Russ.)].

2. Семиглазов В.Ф., Семиглазов В.В., Николаев К.С. и др. Контроль хирургических краев резекции при органосохраняющем лечении рака молочной железы. Онкохирургия 2014;(1):58–63. [Semiglazov V.F., Semiglazov V.V., Nikolaev K.S. et al. Control of surgical resection margins in organ-sparing surgeries for breast cancer. Onkohirurgiya = Cancer Surgery 2014;(1):58–63. (In Russ.)].

3. Семиглазов В.Ф., Семиглазов В.В., Палтуев Р.М. Биологическое обоснование планирования лечения рака молочной железы. Врач 2012;(11):2–4. [Semiglazov V.F., Semiglazov V.V., Paltuev R.M. Biological rationale for planning breast cancer treatment. Vrach = Doctor 2012;(11):2–4. (In Russ.)].

4. Houssami N., Macaskill P., Marinovich M.L. et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 2010;46:3219–32.

5. Lombardi A., Pastore E., Maggi S. et al. Positive margins (R1) risk factors in breast cancer conservative surgery. Breast Cancer (Dove Med Press) 2019;11:243–8. DOI: 10.2147/BCTT.S210788.

6. Wimmer K., Bolliger M., BagoHorvath Z. et al. Impact of surgical margins in breast cancer after preoperative systemic chemotherapy on local recurrence and survival. Ann Surg Oncol 2020;27(5):1700–7.

7. Pahmeyer C., Schablack A., Ratiu D. et al. Occurrence of residual cancer within reexcisions after subcutaneous mastectomy of invasive breast cancer and ductal carcinoma in situ – a retrospective analysis. In Vivo 2020;34 (4):2015–9. DOI: 10.21873/invivo.12000.


Review

For citations:


Rasskazova E.A., Zikiryakhodzhaev A.D., Volchenko N.N.,  Khakimova Sh.G. R1 resection margin after organ-sparing/oncoplastic surgeries for breast cancer. Tumors of female reproductive system. 2021;17(1):12-19. (In Russ.) https://doi.org/10.17650/1994-4098-2021-17-1-12-19

Views: 3644


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1994-4098 (Print)
ISSN 1999-8627 (Online)